Takeda Pharmaceutical Company Limited
Lyophilized recombinant VWF formulations
Last updated:
Abstract:
Long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations are described.
Status:
Grant
Type:
Utility
Filling date:
25 Jan 2019
Issue date:
7 Dec 2021